What It Is
SLU-PP-332 is a novel compound that activates the ERRγ receptor, which is responsible for many of the beneficial adaptations muscles make during exercise.
How It Works
By activating ERRγ, it triggers the same genetic switches that exercise turns on. Increasing mitochondrial density, fat oxidation, and muscle endurance capacity.
Who It's For
Those looking to enhance exercise capacity and endurance. May benefit people who can't exercise at full capacity due to injury or recovery.
Who Should Avoid It
Novel compound with limited long-term data. Discuss thoroughly with provider.
Protocol & Pricing
OBP Pharmacy Price
$3.00/cap
You pay pharmacy price. No markup.
Starting Dose
250mcg/cap
Form
Capsule (250mcg)
Dosing Protocol
1 capsule (250mcg) daily as directed by provider.
Beyond Use Date
180 Days from compounding (USP <797>)
Use within this window from the date your vial is compounded. BUD is set per USP <797> sterile compounding standards and printed on every label.
Stacking Guide
Stacks Well With
Related Peptides
Common questions about SLU-PP-332
- What is SLU-PP-332?
- SLU-PP-332 is an orphan-receptor (ERR) pan-agonist developed at Saint Louis University and described in animal studies as producing some of the metabolic effects of exercise (improved fatty-acid oxidation, mitochondrial biogenesis, improved insulin sensitivity, increased endurance) without actual physical activity. It is investigational; no large-scale human clinical trial data is available yet.
- Does SLU-PP-332 actually replicate exercise effects?
- Animal studies (mice, 2023-2024) showed clear metabolic benefits with SLU-PP-332 administration. Whether those effects translate to humans, in what dose range, and over what timeline is unknown. Use is investigational and supervised by the prescribing provider. SLU-PP-332 is not a substitute for exercise; cardiovascular and musculoskeletal benefits from real training are not fully replaced by any pharmacologic agent.
- How is SLU-PP-332 dosed?
- Compounding protocols extrapolate from animal-study dose ranges and typically deliver oral or subcutaneous doses in the low milligram range. Optimal Balance Pharmacy compounds SLU-PP-332 against PeptideRx prescriptions; your provider sets the starting dose conservatively given limited human data.
- How do I take SLU-PP-332?
- Most compounding-clinic protocols use oral capsule format; the per-dose details are printed on your shipment protocol sheet. Take in the morning or pre-training as directed. Do not dose late in the evening if SLU-PP-332 has any subtle stimulant-like effect for you.
- How is SLU-PP-332 supplied?
- Dispensed by Optimal Balance Pharmacy in capsule form against PeptideRx prescriptions. Each batch is tested for potency and identity; the Certificate of Analysis is published on this product page.